Moreover, in the context of prostate cancer and iron dysmetabolism, an FTH1 gene:pseudogene network appears capable of sequestering oncogenic miRNAs, interfering with competitively endogenous RNA (ceRNA) crosstalk, and effectively bearing out a tumor-suppressive function [18]. This evidence concerns the gene FTH1 and neoplasm.